Inactive Instrument
Probi AB Share Price
Stocks
PROB
SE0001280355
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 08/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 01/08/2025 |
James Henson
COO | Chief Operating Officer | 39 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 13/05/2020 | |
| Chairman | 62 | 01/04/2015 | |
| Director/Board Member | 64 | 04/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/25/03 | Buy | Company | 1,42,586 | 1.2514% | ||
| 21/25/21 | Buy | Company | 28,40,101 | 24.9260% | ||
| 28/24/28 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.29% | - | - | 3.37Cr | |
| +5.98% | +7.45% | +48.94% | +161.56% | 1,00600Cr | |
| +3.32% | +9.63% | +66.81% | +54.96% | 59TCr | |
| +1.89% | +8.28% | +33.34% | +84.56% | 43TCr | |
| -0.66% | +5.11% | +29.26% | +21.27% | 33TCr | |
| +1.41% | +7.74% | +40.56% | +26.27% | 29TCr | |
| -0.44% | +6.05% | +30.66% | +41.09% | 28TCr | |
| +0.73% | +8.53% | -26.22% | -40.85% | 21TCr | |
| +2.01% | +4.57% | +29.15% | +60.40% | 19TCr | |
| +2.40% | +1.89% | +18.22% | +66.18% | 15TCr | |
| Average | +1.66% | +5.96% | +30.08% | +52.83% | 38.73TCr | |
| Weighted average by Cap. | +2.81% | +5.38% | +38.95% | +77.59% |
Employees
-
Sector
Pharmaceuticals
